TREM-1 and TREM-2 Expression on Blood Monocytes Could Help Predict Survival in High-Grade Glioma Patients

Figure 4

Percentage of CD14+ TREM-2+ monocytes in good and bad surviving patients in GBM – G. IV patients. Pts: patients.